Cargando…

Mesenchymal Stromal Cell Therapy in Bronchopulmonary Dysplasia: Systematic Review and Meta‐Analysis of Preclinical Studies

Extreme prematurity is the leading cause of death among children under 5 years of age. Currently, there is no treatment for bronchopulmonary dysplasia (BPD), the most common complication of extreme prematurity. Experimental studies in animal models of BPD suggest that mesenchymal stromal cells (MSCs...

Descripción completa

Detalles Bibliográficos
Autores principales:	Augustine, Sajit, Avey, Marc T., Harrison, Brittany, Locke, Tiffany, Ghannad, Mona, Moher, David, Thébaud, Bernard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Translational Research Articles and Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5702524/ https://www.ncbi.nlm.nih.gov/pubmed/29045045 http://dx.doi.org/10.1002/sctm.17-0126

Ejemplares similares

Are all stem cells equal? Systematic review, evidence map, and meta‐analyses of preclinical stem cell‐based therapies for bronchopulmonary dysplasia
por: Augustine, Sajit, et al.
Publicado: (2019)

Lifetime patient outcomes and healthcare utilization for Bronchopulmonary dysplasia (BPD) and extreme preterm infants: a microsimulation study
por: van Katwyk, Sasha, et al.
Publicado: (2020)

Preempting Bronchopulmonary Dysplasia: Time to Focus on the Placenta?
por: Thébaud, Bernard
Publicado: (2021)

Mesenchymal stromal/stem cells and bronchopulmonary dysplasia
por: Zhang, Shuqing, et al.
Publicado: (2023)

Mesenchymal stromal cells in the development and therapy of bronchopulmonary dysplasia
por: Möbius, Marius A., et al.
Publicado: (2016)

Stem Cells and Their Mediators – Next Generation Therapy for Bronchopulmonary Dysplasia
por: Möbius, Marius A., et al.
Publicado: (2015)

Impact of bronchopulmonary dysplasia on brain and retina
por: Poon, Annie Wing Hoi, et al.
Publicado: (2016)

Cell-Based Strategies to Reconstitute Lung Function in Infants with Severe Bronchopulmonary Dysplasia
por: O'Reilly, Megan, et al.
Publicado: (2012)

The Therapeutic Potential of Stem Cells for Bronchopulmonary Dysplasia: “It’s About Time” or “Not so Fast” ?
por: Ee, Mong Tieng, et al.
Publicado: (2018)

Protective effect of chorioamnionitis on the development of bronchopulmonary dysplasia triggered by postnatal systemic inflammation in neonatal rats
por: Choi, Chang Won, et al.
Publicado: (2016)

Timing of erythropoietin modified mesenchymal stromal cell transplantation for the treatment of experimental bronchopulmonary dysplasia
por: Zhang, Zhaohua, et al.
Publicado: (2018)

Mesenchymal Stromal Cell Extracellular Vesicles: A New Approach for Preventing Bronchopulmonary Dysplasia?
por: Klinger, James R., et al.
Publicado: (2022)

Using Cell-Based Strategies to Break the Link between Bronchopulmonary Dysplasia and the Development of Chronic Lung Disease in Later Life
por: O'Reilly, Megan, et al.
Publicado: (2013)

Perinatal origins of bronchopulmonary dysplasia—deciphering normal and impaired lung development cell by cell
por: Mižíková, I., et al.
Publicado: (2023)

Benefits and obstacles to cell therapy in neonates: The INCuBAToR (Innovative Neonatal Cellular Therapy for Bronchopulmonary Dysplasia: Accelerating Translation of Research)
por: Thébaud, Bernard, et al.
Publicado: (2021)

Definition and Characteristics of Mesenchymal Stromal Cells in Preclinical and Clinical Studies: A Scoping Review
por: Renesme, Laurent, et al.
Publicado: (2022)

NOVEL BIOMARKERS OF BRONCHOPULMONARY DYSPLASIA AND BRONCHOPULMONARY DYSPLASIA-ASSOCIATED PULMONARY HYPERTENSION
por: Sahni, Mitali, et al.
Publicado: (2020)

The National Institutes of Health and guidance for reporting preclinical research
por: Moher, David, et al.
Publicado: (2015)

Phenotypes of Bronchopulmonary Dysplasia
por: Wang, Shih-Hsin, et al.
Publicado: (2020)

Erratum: the National Institutes of Health and guidance for reporting preclinical research
por: Moher, David, et al.
Publicado: (2015)

Efficacy and safety of mesenchymal stromal cells in preclinical models of acute lung injury: a systematic review protocol
por: Lalu, Manoj M, et al.
Publicado: (2014)

Efficacy of Mesenchymal Stromal Cell Therapy for Acute Lung Injury in Preclinical Animal Models: A Systematic Review
por: McIntyre, Lauralyn A., et al.
Publicado: (2016)

Variations in Umbilical Cord Hematopoietic and Mesenchymal Stem Cells With Bronchopulmonary Dysplasia
por: Chaudhury, Sonali, et al.
Publicado: (2019)

Mesenchymal Stem Cell-Derived Extracellular Vesicles for the Treatment of Bronchopulmonary Dysplasia
por: Xi, Yufeng, et al.
Publicado: (2022)

Headway and the remaining hurdles of mesenchymal stem cells therapy for bronchopulmonary dysplasia
por: Tang, Eireen, et al.
Publicado: (2022)

Stromal derived factor-1 mediates the lung regenerative effects of mesenchymal stem cells in a rodent model of bronchopulmonary dysplasia
por: Reiter, Joel, et al.
Publicado: (2017)

Pulmonary Biomarkers of Bronchopulmonary Dysplasia
por: Thompson, Alecia, et al.
Publicado: (2008)

Incidence of Bronchopulmonary Dysplasia in Korea
por: Choi, Chang Won, et al.
Publicado: (2012)

Oxidative Stress and Bronchopulmonary Dysplasia
por: Perrone, Serafina, et al.
Publicado: (2012)

Present and Future of Bronchopulmonary Dysplasia
por: Bonadies, Luca, et al.
Publicado: (2020)

Perspectives on Probiotics and Bronchopulmonary Dysplasia
por: Yang, Kun, et al.
Publicado: (2020)

Pulmonary hypertension in bronchopulmonary dysplasia
por: Hansmann, Georg, et al.
Publicado: (2020)

Bronchopulmonary Dysplasia: Pathogenesis and Pathophysiology
por: Dankhara, Nilesh, et al.
Publicado: (2023)

A Breath of Fresh Air on the Mesenchyme: Impact of Impaired Mesenchymal Development on the Pathogenesis of Bronchopulmonary Dysplasia
por: Chao, Cho-Ming, et al.
Publicado: (2015)

Allogeneic administration of human umbilical cord-derived mesenchymal stem/stromal cells for bronchopulmonary dysplasia: preliminary outcomes in four Vietnamese infants
por: Nguyen, Liem Thanh, et al.
Publicado: (2020)

Intranasal delivery of human umbilical cord Wharton's jelly mesenchymal stromal cells restores lung alveolarization and vascularization in experimental bronchopulmonary dysplasia
por: Moreira, Alvaro, et al.
Publicado: (2019)

Human Platelet Lysate Maintains Stemness of Umbilical Cord-Derived Mesenchymal Stromal Cells and Promote Lung Repair in Rat Bronchopulmonary Dysplasia
por: Liao, Guilian, et al.
Publicado: (2021)

Mesenchymal stem cell-mediated reversal of bronchopulmonary dysplasia and associated pulmonary hypertension
por: Hansmann, Georg, et al.
Publicado: (2012)

Mesenchymal Cells and Bronchopulmonary Dysplasia: New Insights about the Dark Side of Oxygen
por: Popova, Antonia P.
Publicado: (2019)

Application Prospects of Mesenchymal Stem Cell Therapy for Bronchopulmonary Dysplasia and the Challenges Encountered
por: Tong, Yajie, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6ap1rasgprs2e1uqrvgsn4902v